(Q64098738)

English

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)

scientific article published on 13 March 2019

Statements

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE) (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit